Please login to the form below

Not currently logged in
Email:
Password:

Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Adil-Zainulbhai-Cipla

India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director.

A native of India Zainulbhai moved to the US in 1979 to join consulting firm McKinsey & Company. He returned to Mumbai in 2004 to help grow the company's presence in India, working with CEOs of many of the country's largest firms across several industries.

Cipla chairman Y K Hamied said: "Adil's 30 plus years of experience across various industries in India and globally will add a valuable perspective to our board of directors."

Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to the world while building a strong company. I look forward to helping Cipla become even more successful."

29th July 2014

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics